期刊
CURRENT PHARMACEUTICAL DESIGN
卷 15, 期 16, 页码 1844-1853出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138161209788453239
关键词
Cancer; inflammation; chemoresistance; microenvironment; chemotherapy
资金
- Netherlands Organization for Scientific Research [Vidi 917.96.307, Vidi 917.36.347]
- Dutch Cancer Society [NKI 2006-3715, NKI 2006-3486, NKI 2007-3772, NKI 2008-4116]
- Dutch Cancer Society
Acquisition of resistance to the cytotoxic effects of anticancer agents is one of the most significant impediments to effective cancer therapy. Although various cancer-cell intrinsic mechanisms of drug resistance have been identified, chemotherapy resistance remains one of the major causes of cancer patient death. Emerging evidence suggests that the inflammatory tumor-microenvironment plays an important additional role in modulating drug responsiveness and drug resistance; however, underlying mechanisms are still largely unknown. In this review, we discuss data supporting the idea that crosstalk between components of the immune system and cancer cells can influence chemoresistance, and we will speculate on possible underlying pathways and clinical implications. A deeper understanding of the cancer cell-intrinsic and -extrinsic mechanisms of drug resistance will accelerate the development of novel combinatorial anticancer therapies in which drug resistance is prevented or reversed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据